sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Next Generation Cancer Diagnostic Devices Market Research Report 2021

Global Next Generation Cancer Diagnostic Devices Market Research Report 2021

Home / Categories / Healthcare
Global Next Generation Cancer Diagnostic Devices Market Research Report 2021
Global Next Generation Cancer Diagnostic...
Report Code
RO1/130/5130

Publish Date
28/Mar/2024

Pages
119
PRICE
$ 2900/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5800/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
List of Tables
Table 1. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Next Generation Cancer Diagnostic Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Next Generation Cancer Diagnostic Devices Covered in This Study
Table 5. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers (2016-2021)
Table 7. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 12. Global Next Generation Cancer Diagnostic Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Next Generation Cancer Diagnostic Devices Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2021)
Table 17. Global Next Generation Cancer Diagnostic Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2021)
Table 20. North America Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2016-2021)
Table 39. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 40. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2016-2021)
Table 42. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2016-2021)
Table 44. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 45. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Next Generation Cancer Diagnostic Devices Revenue Share by Application (2016-2021)
Table 47. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Application (2016-2021)
Table 48. Roche Holding Ltd.?Switzerland) Corporation Information
Table 49. Roche Holding Ltd.?Switzerland) Description and Business Overview
Table 50. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product
Table 52. Roche Holding Ltd.?Switzerland) Recent Developments/Updates
Table 53. Abbott Laboratories(US) Corporation Information
Table 54. Abbott Laboratories(US) Description and Business Overview
Table 55. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product
Table 57. Abbott Laboratories(US) Recent Developments/Updates
Table 58. Siemens Healthcare(Germany) Corporation Information
Table 59. Siemens Healthcare(Germany) Description and Business Overview
Table 60. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product
Table 62. Siemens Healthcare(Germany) Recent Developments/Updates
Table 63. Agilent Technologies Inc(Germany) Corporation Information
Table 64. Agilent Technologies Inc(Germany) Description and Business Overview
Table 65. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product
Table 67. Agilent Technologies Inc(Germany) Recent Developments/Updates
Table 68. Illumina Inc.(US) Corporation Information
Table 69. Illumina Inc.(US) Description and Business Overview
Table 70. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 72. Illumina Inc.(US) Recent Developments/Updates
Table 73. Becton Dickinson and Co.(US) Corporation Information
Table 74. Becton Dickinson and Co.(US) Description and Business Overview
Table 75. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product
Table 77. Becton Dickinson and Co.(US) Recent Developments/Updates
Table 78. QIAGEN N.V.(Germany) Corporation Information
Table 79. QIAGEN N.V.(Germany) Description and Business Overview
Table 80. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product
Table 82. QIAGEN N.V.(Germany) Recent Developments/Updates
Table 83. Affymetrix Inc.(US) Corporation Information
Table 84. Affymetrix Inc.(US) Description and Business Overview
Table 85. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 87. Affymetrix Inc.(US) Recent Developments/Updates
Table 88. Johnson & Johnson(US) Corporation Information
Table 89. Johnson & Johnson(US) Description and Business Overview
Table 90. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product
Table 92. Johnson & Johnson(US) Recent Developments/Updates
Table 93. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 94. Thermo Fisher Scientific Inc.(US) Description and Business Overview
Table 95. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 97. Thermo Fisher Scientific Inc.(US) Recent Developments/Updates
Table 98. GE Healthcare(England) Corporation Information
Table 99. GE Healthcare(England) Description and Business Overview
Table 100. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product
Table 102. GE Healthcare(England) Recent Developments/Updates
Table 103. Life Technologies Corp.(US) Corporation Information
Table 104. Life Technologies Corp.(US) Description and Business Overview
Table 105. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 107. Life Technologies Corp.(US) Recent Developments/Updates
Table 108. Luminex Corp.(US) Corporation Information
Table 109. Luminex Corp.(US) Description and Business Overview
Table 110. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 112. Luminex Corp.(US) Recent Developments/Updates
Table 113. Cepheid Inc.(US) Corporation Information
Table 114. Cepheid Inc.(US) Description and Business Overview
Table 115. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 117. Cepheid Inc.(US) Recent Developments/Updates
Table 118. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 119. Allegro Diagnostics Corp.(Brazil) Description and Business Overview
Table 120. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product
Table 122. Allegro Diagnostics Corp.(Brazil) Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Next Generation Cancer Diagnostic Devices Distributors List
Table 126. Next Generation Cancer Diagnostic Devices Customers List
Table 127. Next Generation Cancer Diagnostic Devices Market Trends
Table 128. Next Generation Cancer Diagnostic Devices Growth Drivers
Table 129. Next Generation Cancer Diagnostic Devices Market Restraints
Table 130. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2022-2027) & (K Pcs)
Table 131. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2022-2027) & (K Pcs)
Table 135. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2022-2027) & (K Pcs)
Table 139. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Next Generation Cancer Diagnostic Devices
Figure 2. Global Next Generation Cancer Diagnostic Devices Market Share by Type in 2020 & 2027
Figure 3. Next Generation Sequencing Product Picture
Figure 4. qPCR & Multiplexing Product Picture
Figure 5. Lab-on- a- chip (LOAC) Product Picture
Figure 6. Protein Microarrays Product Picture
Figure 7. DNA Microarrays Product Picture
Figure 8. Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure 9. Global Next Generation Cancer Diagnostic Devices Market Share by Application in 2020 & 2027
Figure 10. Biomarker Development
Figure 11. CTC Analysis
Figure 12. Proteomic Analysis
Figure 13. Epigenetic Analysis
Figure 14. Genetic Analysis
Figure 15. Global Next Generation Cancer Diagnostic Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Next Generation Cancer Diagnostic Devices Market Size 2016-2027 (US$ Million)
Figure 17. Global Next Generation Cancer Diagnostic Devices Sales 2016-2027 (K Pcs)
Figure 18. Global Next Generation Cancer Diagnostic Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 19. Next Generation Cancer Diagnostic Devices Sales Share by Manufacturers in 2020
Figure 20. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers in 2020
Figure 21. The Global 5 and 10 Largest Next Generation Cancer Diagnostic Devices Players: Market Share by Revenue in 2020
Figure 22. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 23. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2021)
Figure 24. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region in 2020
Figure 25. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2016-2021)
Figure 26. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region in 2020
Figure 27. U.S. Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Germany Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. France Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. U.K. Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Italy Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Russia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Japan Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. South Korea Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. India Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Australia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Taiwan Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Indonesia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Thailand Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Malaysia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Philippines Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Vietnam Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. U.A.E Next Generation Cancer Diagnostic Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of Next Generation Cancer Diagnostic Devices by Type (2016-2021)
Figure 52. Sales Market Share of Next Generation Cancer Diagnostic Devices by Application (2016-2021)
Figure 53. Sales Market Share of Next Generation Cancer Diagnostic Devices by Application in 2020
Figure 54. Revenue Share of Next Generation Cancer Diagnostic Devices by Application (2016-2021)
Figure 55. Revenue Share of Next Generation Cancer Diagnostic Devices by Application in 2020
Figure 56. Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Figure 57. Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure 58. Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
LIST OF FIGURE

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com